Review article: Drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis

Nephrology

Volumn 14, Issue 1, 2009, Pages 33-41

  Gao, Ying ^a   Zhao, Ming Hui ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Anti neutrophil cytoplasmic antibodies (ANCA); Drug induced; Vasculitis

Indexed keywords

ADALIMUMAB; ALLOPURINOL; ANTIBIOTIC AGENT; ANTITHYROID AGENT; BENZYLTHIOURACIL; CARBIMAZOLE; CEFOTAXIME; CLOZAPINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; ETANERCEPT; HYDRALAZINE; INFLIXIMAB; LEVAMISOLE; METHYLPREDNISOLONE; MINOCYCLINE; MONTELUKAST; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEUTROPHIL CYTOPLASMIC ANTIBODY; PENICILLAMINE; PHENYTOIN; PREDNISONE; PROPYLTHIOURACIL; PSYCHOTROPIC AGENT; SALAZOSULFAPYRIDINE; THIAMAZOLE; THIORIDAZINE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; ZAFIRLUKAST;

ANCA ASSOCIATED VASCULITIS; CHURG STRAUSS SYNDROME; CLINICAL FEATURE; DRUG INDUCED DISEASE; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TREATMENT DURATION; TREATMENT RESPONSE; VASCULITIS;

ANIMALS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; HUMANS; LEUKOTRIENE ANTAGONISTS; PEROXIDASE; PROGNOSIS; PROPYLTHIOURACIL; VASCULITIS;

EID: 63149185361     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2009.01100.x     Document Type: Review

References (91)

1. Harper L, Savage CO. Pathogenesis of ANCA-associated systemic vasculitis. J. Pathol. 2000 190 : 349 59.
2. Xiao H, Heeringa P, Hu P et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J. Clin. Invest. 2002 110 : 955 63.
3. Merkel PA. Drug-induced vasculitis. Rheum. Dis. Clin. North Am. 2001 27 : 849 62.
4. Dolman KM, Gans RO, Vervaat TJ et al. Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet 1993 342 : 651 2.
5. Gao Y, Zhao MH, Guo XH, Xin G, Gao Y, Wang HY. The prevalence and target antigens of anti-thyroid drugs induced antineutrophil cytoplasmic antibodies (ANCA) in Chinese patients with hyperthyroidism. Endocr. Res. 2004 30 : 205 13.
6. Zhao MH, Chen M, Gao Y, Wang HY. Propylthiouracil-induced anti-neutrophil cytoplasmic antibody-associated vasculitis. Kidney Int. 2006 69 : 1477 81.
7. Nässberger L, Johansson AC, Björck S, Sjöholm AG. Antibodies to neutrophil granulocyte myeloperoxidase and elastase: Autoimmune responses in glomerulonephritis due to hydralazine treatment. J. Intern. Med. 1991 229 : 261 5.
8. Almroth G, Eneström S, Hed J, Samuelsson I, Sjöström P. Autoantibodies to leucocyte antigens in hydralazine-associated nephritis. J. Intern. Med. 1992 231 : 37 42.
9. Stokes MB, Foster K, Markowitz GS et al. Development of glomerulonephritis during anti-TNF-alpha therapy for rheumatoid arthritis. Nephrol. Dial. Transplant. 2005 20 : 1400 406.
10. De Bandt M, Saint-Marcoux B. Tumour necrosis factor alpha blockade and the risk of vasculitis. Ann. Rheum. Dis. 2006 65 : 1534 5.
11. Simms R, Kipgen D, Dahill S, Marshall D, Rodger RS. ANCA-associated renal vasculitis following anti-tumor necrosis factor alpha therapy. Am. J. Kidney Dis. 2008 51 : e11 14.
12. Salerno SM, Ormseth EJ, Roth BJ, Meyer CA, Christensen ED, Dillard TA. Sulfasalazine pulmonary toxicity in ulcerative colitis mimicking clinical features of Wegener's granulomatosis. Chest 1996 110 : 556 9.
13. Denissen NH, Peters JG, Masereeuw R, Barrera P. Can sulfasalazine therapy induce or exacerbate Wegener's granulomatosis? Scand. J. Rheumatol. 2008 37 : 72 4.
14. Bienaimé F, Clerbaux G, Plaisier E, Mougenot B, Ronco P, Rougier JP. D-Penicillamine-induced ANCA-associated crescentic glomerulonephritis in Wilson disease. Am. J. Kidney Dis. 2007 50 : 821 5.
15. Locke IC, Worrall JG, Leaker B, Black CM, Cambridge G. Autoantibodies to myeloperoxidase in systemic sclerosis. J. Rheumatol. 1997 24 : 86 9.
16. Sethi S, Sahani M, Oei LS. ANCA-positive crescentic glomerulonephritis associated with minocycline therapy. Am. J. Kidney. Dis. 2003 42 : E27 31.
17. Sato H, Hattori M, Fujieda M et al. High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves' disease treated with propylthiouracil. J. Clin. Endocrinol. Metab. 2000 85 : 4270 73.
18. Sera N, Ashizawa K, Ando T et al. Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease. Thyroid 2000 10 : 595 9.
19. Gunton JE, Stiel J, Clifton-Bligh P, Wilmshurst E, McElduff A. Prevalence of positive anti-neutrophil cytoplasmic antibody (ANCA) in patients receiving anti-thyroid medication. Eur. J. Endocrinol. 2000 142 : 587.
20. Wada N, Mukai M, Kohno M, Notoya A, Ito T, Yoshioka N. Prevalence of serum anti-myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) in patients with Graves' disease treated with propylthiouracil and thiamazole. Endocr. J. 2002 49 : 329 34.
21. Noh JY, Asari T, Hamada N et al. Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) in Graves' disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations. Clin. Endocrinol. (Oxf.) 2001 54 : 651 4.
22. Bilu Martin D, Deng A, Gaspari A, Pearson F. Perinuclear antineutrophil cytoplasmic antibody-associated vasculitis in a patient with Graves' disease treated with methimazole. Skinmed 2006 5 : 302 5.
23. Calañas-Continente A, Espinosa M, Manzano-García G, Santamaría R, Lopez-Rubio F, Aljama P. Necrotizing glomerulonephritis and pulmonary hemorrhage associated with carbimazole therapy. Thyroid 2005 15 : 286 8.
24. Hachicha M, Kammoun T, Ben Romdhane W et al. [Vasculitis with renal involvement and antineutrophil cytoplasmic antibodies (ANCA) in a child receiving benzylthiouracil.] Nephrol. Ther. 2007 3 : 147 51 In French M, Maslinski W. Laboratory changes on anti-tumor necrosis factor treatment in rheumatoid arthritis. Curr. Opin. Rheumatol. 2003 15 : 267 73.
25. Lawson TM, Amos N, Bulgen D, Williams BD. Minocycline-induced lupus: Clinical features and response to rechallenge. Rheumatology (Oxford) 2001 40 : 329 35.
26. Dunphy J, Oliver M, Rands AL, Lovell CR, McHugh NJ. Antineutrophil cytoplasmic antibodies and HLA class II alleles in minocycline-induced lupus-like syndrome. Br. J. Dermatol. 2000 142 : 461 7.
27. Marzo-Ortega H, Baxter K, Strauss RM et al. Is minocycline therapy in acne associated with antineutrophil cytoplasmic antibody positivity? A cross-sectional study. Br. J. Dermatol. 2007 156 : 1005 9.
28. Wiik A. Drug-induced vasculitis. Curr. Opin. Rheumatol. 2008 20 : 35 9.
29. Choi HK, Merkel PA, Niles JL. ANCA-positive vasculitis associated with allopurinol therapy. Clin. Exp. Rheumatol. 1998 16 : 743 4.
30. Feriozzi S, Muda AO, Gomes V, Montanaro M, Faraggiana T, Ancarani E. Cephotaxime-associated allergic interstitial nephritis and MPO-ANCA positive vasculitis. Ren. Fail. 2000 22 : 245 51.
31. Jaunkalns R, Shear NH, Sokoluk B, Gardner D, Claas F, Uetrecht JP. Antimyeloperoxidase antibodies and adverse reactions to clozapine. Lancet 1992 339 : 1611 12.
32. Rongioletti F, Ghio L, Ginevri F et al. Purpura of the ears: A distinctive vasculopathy with circulating autoantibodies complicating long-term treatment with levamisole in children. Br. J. Dermatol. 1999 140 : 948 51.
33. Powell J, Grech H, Holder J. A boy with cutaneous necrosis occurring during treatment with levamisole. Clin. Exp. Dermatol. 2002 27 : 32 3.
34. Parry RG, Gordon P, Mason JC, Marley NJ. Phenytoin-associated vasculitis and ANCA positivity: A case report. Nephrol. Dial. Transplant. 1996 11 : 357 9.
35. Greenfield JR, McGrath M, Kossard S, Charlesworth JA, Campbell LV. ANCA-positive vasculitis induced by thioridazine: Confirmed by rechallenge. Br. J. Dermatol. 2002 147 : 1265 7.
36. Harrold LR, Patterson MK, Andrade SE et al. Asthma drug use and the development of Churg-Strauss syndrome (CSS). Pharmacoepidemiol. Drug. Saf. 2007 16 : 620 26.
37. Hauser T, Mahr A, Metzler C et al. The leucotriene receptor antagonist montelukast and the risk of Churg-Strauss syndrome: A case-crossover study. Thorax 2008 63 : 677 82.
38. Mor A, Pillinger MH, Wortmann RL, Mitnick HJ. Drug-induced arthritic and connective tissue disorders. Semin. Arthritis. Rheum 2008 38 : 249 64.
39. Jamaleddine G, Diab K, Tabbarah Z, Tawil A, Arayssi T. Leukotriene antagonists and the Churg-Strauss syndrome. Semin. Arthritis Rheum. 2002 31 : 218 27.
40. Slot MC, Links TP, Stegeman CA, Tervaert JW. Occurrence of antineutrophil cytoplasmic antibodies and associated vasculitis in patients with hyperthyroidism treated with anti-thyroid drugs: A long-term follow-up study. Arthritis Rheum. 2005 53 : 108 13.
41. Choi HK, Slot MC, Pan G, Weissbach CA, Niles JL, Merkel PA. Evaluation of antineutrophil cytoplasmic antibody seroconversion induced by minocycline, sulfasalazine, or penicillamine. Arthritis Rheum. 2000 43 : 2488 92.
42. ten Holder SM, Joy MS, Falk RJ. Cutaneous and systemic manifestations of drug-induced vasculitis. Ann. Pharmacother. 2002 36 : 130 47.
43. Jiang X, Khursigara G, Rubin RL. Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils. Science 1994 266 : 810 13.
44. von Schmiedeberg S, Goebel C, Gleichmann E, Uetrecht J. Neutrophils and drug metabolism. Science 1995 268 : 585 6.
45. Waldhauser L, Uetrecht J. Antibodies to myeloperoxidase in propylthiouracil-induced autoimmune disease in the cat. Toxicology 1996 114 : 155 62.
46. Aloush V, Litinsky I, Caspi D, Elkayam O. Propylthiouracil-induced autoimmune syndromes: Two distinct clinical presentations with different course and management. Semin. Arthritis Rheum. 2006 36 : 4 9.
47. Palmblad J, Papadaki HA, Eliopoulos G. Acute and chronic neutropenias. What is new? J. Intern. Med. 2001 250 : 476 91.
48. Gilligan HM, Bredy B, Brady HR et al. Antineutrophil cytoplasmic autoantibodies interact with primary granule constituents on the surface of apoptotic neutrophils in the absence of neutrophil priming. J. Exp. Med. 1996 184 : 2231 41.
49. Ralston DR, Marsh CB, Lowe MP, Wewers MD. Antineutrophil cytoplasmic antibodies induce monocyte IL-8 release. Role of surface proteinase-3, alpha1-antitrypsin, and Fcgamma receptors. J. Clin. Invest. 1997 100 : 1416 24.
50. Zhang AH, Chen M, Gao Y, Zhao MH, Wang HY. Inhibition of oxidation activity of myeloperoxidase (MPO) by propylthiouracil (PTU) and anti-MPO antibodies from patients with PTU-induced vasculitis. Clin. Immunol. 2007 122 : 187 93.
51. Moosig F, Csernok E, Kumanovics G, Gross WL. Opsonization of apoptotic neutrophils by anti-neutrophil cytoplasmic antibodies (ANCA) leads to enhanced uptake by macrophages and increased release of tumour necrosis factor-alpha (TNF-alpha). Clin. Exp. Immunol. 2000 122 : 499 503.
52. Sanders JS, Stegeman CA, Kallenberg CG. The Th1 and Th2 paradigm in ANCA-associated vasculitis. Kidney Blood Press. Res. 2003 26 : 215 20.
53. Hartung AD, Bohnert A, Hackstein H, Ohly A, Schmidt KL, Bein G. Th2-mediated atopic disease protection in Th1-mediated rheumatoid arthritis. Clin. Exp. Rheumatol. 2003 21 : 481 4.
54. Segal R, Dayan M, Zinger H, Habut B, Shearer GM, Mozes E. The effect of IL-12 on clinical and laboratory aspects of experimental SLE in young and aging mice. Exp. Gerontol. 2003 38 : 661 8.
55. Becher B, Blain M, Giacomini PS, Antel JP. Inhibition of Th1 polarization by soluble TNF receptor is dependent on antigen-presenting cell-derived IL-12. J. Immunol. 1999 162 : 684 8.
56. Roitberg-Tambur A, Witt CS, Friedmann A et al. Comparative analysis of HLA polymorphism at the serologic and molecular level in Moroccan and Ashkenazi Jews. Tissue Antigens 1995 46 : 104 10.
57. Cambridge G, Wallace H, Bernstein RM, Leaker B. Autoantibodies to myeloperoxidase in idiopathic and drug-induced systemic lupus erythematosus and vasculitis. Br. J. Rheumatol. 1994 33 : 109 14.
58. Morita S, Ueda Y, Eguchi K. Anti-thyroid drug-induced ANCA-associated vasculitis: A case report and review of the literature. Endocr. J. 2000 47 : 467 70.
59. Ye H, Gao Y, Guo XH, Zhao MH. Titre and affinity of propylthiouracil- induced anti-myeloperoxidase antibodies are closely associated with the development of clinical vasculitis. Clin. Exp. Immunol. 2005 142 : 116 19.
60. Fujieda M, Suzuki K, Sato H et al. Epitope analysis of myeloperoxidase-specific antineutrophil cytoplasmic autoantibodies (MPO-ANCA) in childhood onset Graves' disease treated with propylthiouracil. Clin. Nephrol. 2005 63 : 437 45.
61. Yu F, Zhao MH, Zhang YK, Zhang Y, Wang HY. Anti-endothelial cell antibodies (AECA) in patients with propylthiouracil (PTU)-induced ANCA positive vasculitis are associated with disease activity. Clin. Exp. Immunol. 2005 139 : 569 74.
62. Gao Y, Chen M, Ye H, Guo XH, Zhao MH, Wang HY. The target antigens of antineutrophil cytoplasmic antibodies (ANCA) induced by propylthiouracil. Int. Immunopharmacol. 2007 7 : 55 60.
63. Gao Y, Ye H, Yu F, Guo XH, Zhao MH. Anti-myeloperoxidase IgG subclass distribution and avidity in sera from patients with propylthiouracil-induced antineutrophil cytoplasmic antibodies associated vasculitis. Clin. Immunol. 2005 117 : 87 93.
64. Ye H, Zhao MH, Gao Y, Guo XH, Wang HY. Anti-myeloperoxidase antibodies in sera from patients with propylthiouracil-induced vasculitis might recognize restricted epitopes on myeloperoxidase molecule. Clin. Exp. Immunol. 2004 138 : 179 82.
65. Gross WL, Trabandt A, Reinhold-Keller E. Diagnosis and evaluation of vasculitis. Rheumatology (Oxford) 2000 39 : 245 52.
66. Yu F, Chen M, Gao Y et al. Clinical and pathological features of renal involvement in propylthiouracil-associated ANCA-positive vasculitis. Am. J. Kidney. Dis. 2007 49 : 607 14.
67. Maguchi S, Fukuda S, Chida E, Terayama Y. Myeloperoxidase-antineutrophil cytoplasmic antibody-associated sensorineural hearing loss. Auris. Nasus. Larynx. 2001 28 (Suppl S103 6.
68. Sano M, Kitahara N, Kunikata R. Progressive bilateral sensorineural hearing loss induced by an anti-thyroid drug. ORL. J. Otorhinolaryngol. Relat. Spec. 2004 66 : 281 5.
69. Colakovski H, Lorber DL. Propylthiouracil-induced perinuclear-staining antineutrophil cytoplasmic autoantibody-positive vasculitis in conjunction with pericarditis. Endocr. Pract. 2001 7 : 37 9.
70. Darben T, Savige J, Prentice R, Paspaliaris B, Chick J. Pyoderma gangrenosum with secondary pyarthrosis following propylthiouracil. Australas. J. Dermatol. 1999 40 : 144 6.
71. Hong SB, Lee MH. A case of propylthiouracil-induced pyoderma gangrenosum associated with antineutrophil cytoplasmic antibody. Dermatology 2004 208 : 339 41.
72. Vanek C, Samuels MH. Central nervous system vasculitis caused by propylthiouracil therapy: A case report and literature review. Thyroid 2005 15 : 80 84.
73. Abe T, Nogawa S, Tanahashi N, Shiraishi J, Ikeda E, Suzuki N. Cerebral pachyleptomeningitis associated with MPO-ANCA induced by PTU therapy. Intern. Med. 2007 46 : 247 50.
74. Miller RM, Savige J, Nassis L, Cominos BI. Antineutrophil cytoplasmic antibody (ANCA)-positive cutaneous leucocytoclastic vasculitis associated with anti-thyroid therapy in Graves' disease. Australas. J. Dermatol. 1998 39 : 96 9.
75. Zhang H, Zhao MH, He B, Wang GF. [Propylthiouracil induced pulmonary vasculitis in one patient.] Zhongguo Lin Chuang Yao Li Xue Za Zhi 2003 19 : 233 6 In Chinese Y, Chen M, Ye H, Yu F, Guo XH, Zhao MH. Long-term outcomes of patients with propylthiouracil-induced anti-neutrophil cytoplasmic auto-antibody-associated vasculitis. Rheumatology (Oxford) 2008 47 : 1515 20.
76. Fujieda M, Hattori M, Kurayama H, Koitabashi Y. Members and Coworkers of the Japanese Society for Pediatric Nephrology. Clinical features and outcomes in children with antineutrophil cytoplasmic autoantibody-positive glomerulonephritis associated with propylthiouracil treatment. J. Am. Soc. Nephrol. 2002 13 : 437 45.
77. Gao Y, Chen M, Ye H, Guo XH, Zhao MH, Wang HY. Follow-up of avidity and titre of anti-myeloperoxidase antibodies in sera from patients with propylthiouracil-induced vasculitis. Clin. Endocrinol. (Oxf.) 2007 66 : 543 7.
78. Matsubara K, Nigami H, Harigaya H, Osaki M, Baba K. Myeloperoxidase antineutrophil cytoplasmic antibody positive vasculitis during propylthiouracil treatment: Successful management with oral corticosteroids. Pediatr. Int. 2000 42 : 170 73.
79. Chen YX, Yu HJ, Ni LY et al. Propylthiouracil-associated antineutrophil cytoplasmic autoantibody-positive vasculitis: Retrospective study of 19 cases. J. Rheumatol. 2007 34 : 2451 6.
80. Schnabel A, Reuter M, Csernok E, Richter C, Gross WL. Subclinical alveolar bleeding in pulmonary vasculitides: Correlation with indices of disease activity. Eur. Respir. J. 1999 14 : 118 24.
81. Watts RA, Lane SE, Bentham G, Scott DG. Epidemiology of systemic vasculitis: A ten-year study in the United Kingdom. Arthritis Rheum. 2000 43 : 414 19.
82. Bonaci-Nikolic B, Nikolic MM, Andrejevic S, Zoric S, Bukilica M. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by anti-thyroid drugs: Comparison with idiopathic ANCA vasculitides. Arthritis Res. Ther. 2005 7 : R1072 81.
83. Chastain MA, Russo GG, Boh EE, Chastain JB, Falabella A, Millikan LE. Propylthiouracil hypersensitivity: Report of two patients with vasculitis and review of the literature. J. Am. Acad. Dermatol. 1999 41 : 757 64.
84. Sturkenboom MC, Meier CR, Jick H, Stricker BH. Minocycline and lupuslike syndrome in acne patients. Arch. Intern. Med. 1999 159 : 493 7.
85. Cameron HA, Ramsay LE. The lupus syndrome induced by hydralazine: A common complication with low dose treatment. Br. Med. J. (Clin. Res. Ed.) 1984 289 : 410 12.
86. Choi HK, Merkel PA, Walker AM, Niles JL. Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: Prevalence among patients with high titers of antimyeloperoxidase antibodies. Arthritis Rheum. 2000 43 : 405 13.
87. Ohtsuka M, Yamashita Y, Doi M, Hasegawa S. Propylthiouracil-induced alveolar haemorrhage associated with antineutrophil cytoplasmic antibody. Eur. Respir. J. 1997 10 : 1405 7.
88. Helfgott SM, Smith RN. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 21-2002. A 21-year-old man with arthritis during treatment for hyperthyroidism. N. Engl. J. Med. 2002 347 : 122 30.
89. Seligman VA, Bolton PB, Sanchez HC, Fye KH. Propylthiouracil-induced microscopic polyangiitis. J. Clin. Rheumatol. 2001 7 : 170 74.
90. Poomthavorn P, Mahachoklertwattana P, Tapaneya-Olarn W, Chuansumrit A, Chunharas A. Antineutrophilic cytoplasmic antibody-positive systemic vasculitis associated with propylthiouracil therapy: Report of 2 children with Graves' disease. J. Med. Assoc. Thai 2002 85 (Suppl 4 S1295 301.
91. Gunton JE, Stiel J, Caterson RJ, McElduff A. Clinical case seminar: Anti-thyroid drugs and antineutrophil cytoplasmic antibody positive vasculitis. A case report and review of the literature. J. Clin. Endocrinol. Metab. 1999 84 : 13 16.